Okay. First I'll talk about automation and a small subset of that will be robotics. So automation is a very difficult initiative to execute. We knew that going in, but we also knew that once we did it, and for each, you know, when we made progress each element of progress that we make would (Technical Difficulty) going and arduous. But the results in the last few quarters, you could just see the margins and we can track it back to the number of technicians that we have, how efficient they are, we have productivity ratings for each technician, how often are they on the bench, how effective are they when they're on the bench, how much automation are they using, how many calibrations are they doing that are redundant to the time they spent doing automated cal, these are type of KPIs we're tracking. So we know it's working and will continue to work. What inning are we in? If I had to characterize it, I used to say we're the first, second inning. We're probably in the fifth inning of that game that we've progressed from the first, second, third inning to the fifth inning. There's still plenty of work to do. Robotics is a subset of that, you know, the Irish company we bought is a robotics company. And we are now doing mass calibrations for example in Philadelphia in our LA labs, we have two robots in each lab. In Ireland, that robotics team, they're now working on digital multi-meters, and I think on deck is temperature and pressure after that. So, again not a fast process, but robotics is actually faster than traditional automation. And like I said, we've already got robots running. And so, these are things that are going to help us get to that high 30s from the mid-30s and beyond. And that's our ultimate goal. So we're pleased with that progress. The Irish market itself, as far as developing it, for the calibration business, we bought that very, very small company, we've got some interesting plans in the works to try to grow that organically. It's really early for us to get into too many details on that. But we intend on growing our calibration business in the Irish market. And really kind of exclusively in the Irish market as far as Europe because that's where our cal lab is, that's where we'll do work, and that's where we'll grow organically. Unlike the NEXA business that's more scalable throughout Europe, because it's just easier to grow that business and to follow our customers throughout the European footprint, calibration will be in Ireland. And you know, it's early days there, but we intend on growing it organically for sure. Hope that -- I hope that's helpful, Ted.